April 29, 2024
The 2023 OND Annual report captures the office’s achievements, including notable drug approvals, guidances, publications, and staff’s involvement in public meetings, workshops, webinars, and conferences. This […]
April 29, 2024
(Reuters) – Health insurance plans run by U.S. states must cover gender-affirming surgeries for transgender people, a U.S. appeals court ruled on Monday. The 8-6 opinion […]
April 29, 2024
Several times a year the Center for Drug Evaluation and Research sends out an update to share information on new developments, opportunities, and initiatives in regulatory […]
April 29, 2024
The Role of Scientific Consortia in Drug Development Background Information The Critical Path Initiative (CPI), and the Strategic Plan for Advancing Regulatory Science Initiative seek to […]
April 29, 2024
(Reuters) -The U.S. Food and Drug Administration’s website showed on Monday one dose of Novo Nordisk’s weight-loss drug Wegovy as available after being in short supply, […]
April 29, 2024
TOPLINE: Immune checkpoint inhibitors (ICIs) are now widely used immunotherapies for many cancers, but their use in pregnancy is discouraged because of the lack of safety […]
April 29, 2024
By February of 2022, Ella, a 25-year-old behavioral interventionist in Colorado Springs, Colorado, was sick with strep-like symptoms for the third time in 3 months. She […]
April 29, 2024
Most people experiencing homelessness have mental health disorders, according to a systematic review and meta-analysis. In an examination of studies that included nearly 50,000 participants, the […]
April 29, 2024
LIVERPOOL, ENGLAND — Optimizing how people experiencing a gout flare are managed in hospital and then followed-up afterwards can substantially increase the uptake of guideline-recommended urate-lowering […]